sotalol has been researched along with procainamide in 56 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 6 (10.71) | 18.7374 |
1990's | 24 (42.86) | 18.2507 |
2000's | 14 (25.00) | 29.6817 |
2010's | 12 (21.43) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Creveling, CR; Daly, JW; Lewandowski, GA; McNeal, ET | 1 |
Gao, F; Lombardo, F; Shalaeva, MY; Tupper, KA | 1 |
Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Glen, RC; Lowe, R; Mitchell, JB | 1 |
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
Brown, AM; Bruening-Wright, A; Kramer, J; Kuryshev, YA; Myatt, G; Obejero-Paz, CA; Verducci, JS | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Bellman, K; Knegtel, RM; Settimo, L | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Honerjäger, P; Schmidt, G | 1 |
Blackburn, KJ; Burges, RA; Gwilt, M; Higgins, AJ; Milne, AA; Solca, AM | 1 |
Campbell, TJ | 1 |
Bandyopadhyay, S; Klaunig, JE; Somani, P | 1 |
Anderson, JL | 1 |
Nademanee, K; Singh, BN | 1 |
Clement, DL; Colardyn, F; Jordaens, LJ | 1 |
Huang, SK; Marcus, FI | 1 |
Constantin, L; Hopson, R; Kienzle, MG; Martins, JB; McCue, ML; Wendt, DJ | 1 |
Crocker, K; Schwartz, J; Somberg, JC; Wynn, J | 1 |
Lidell, C; Rehnqvist, N; Rønnevik, PK; Sjögren, A; Yli-Uotila, RJ | 1 |
Krafte, DS; Volberg, WA | 1 |
Cui, G; Sager, P; Sen, L; Singh, BN; Uppal, P | 1 |
Imaizumi, Y; Ishii, Y; Kurihara, A; Muraki, K; Watanabe, M | 1 |
Baskin, EP; Guinosso, PJ; Hamill, T; Lynch, JJ; Nutt, EM; Salata, JJ; Woods, CM | 1 |
Biblo, LA; Carlson, MD; Waldo, AL | 1 |
Kehoe, R; Quart, B; Scheinman, M; Singh, BN; Woosley, RL | 1 |
Janssen, JH | 1 |
Damle, RS; Kelly, PA; Mann, DE; Reiter, MJ | 1 |
Fromm, BS; Lehmann, MH; Makkar, RR; Meissner, MD; Steinman, RT | 1 |
Roden, DM | 1 |
Bourne, GW; Nattel, S; Talajic, M; Villemaire, C; Wang, J; Wang, Z | 1 |
Lee, EW; Lee, KS; Tsai, TD | 1 |
Berman, N; Dorian, P; Hardy, J; Mitchell, J; Newman, D | 1 |
Dorian, P; Ham, M; Lee, SD; Newman, D | 1 |
Chang, MS; Chen, SA; Chen, YJ; Chiang, CE; Chiou, CW; Feng, AN; Huang, JL; Lee, SH; Tai, CT; Ueng, KC; Wen, ZC; Yu, WC | 1 |
Chang, MS; Chen, SA; Chiang, CE; Ding, YA; Hsieh, MH; Tai, CT; Wen, ZC | 1 |
Chang, MS; Chen, SA; Ding, YA; Feng, AN; Kuo, BI; Lee, SH; Tai, CT; Yu, WC | 1 |
Chang, MS; Chen, SA; Ding, YA; Feng, AN; Tai, CT; Wen, ZC; Yu, WC | 1 |
Al-Khalidi, H; Brooks, RR; Drexler, AP; Kostreva, DR; Maynard, AE | 1 |
Dell'Orfano, JT; Luck, JC; Naccarelli, GV; Patel, HM; Wolbrette, DL | 1 |
Klein, GJ; Krahn, AD; Lee, JK; Simpson, C; Skanes, A; Spindler, B; Yee, R; Zarnke, K | 1 |
Atkins, CE; DeFrancesco, TC; Gordon, SG; Hamlin, RL; Keene, BW; Meurs, KM; Miller, MW; Moise, NS; Spier, AW; Wright, NA | 1 |
Klein, GJ; Krahn, AD; Lee, JK; Simpson, C; Skanes, A; Yee, R; Zarnke, K | 1 |
Chen, X; Huang, J; Ideker, RE; Jin, Q; Smith, WM | 1 |
Tang, L | 1 |
Goodman, IS; Lu, CJ | 1 |
Barrell, EA; Fiorenza, LR; Kraus, MS; Perkins, GA | 1 |
Koyfman, A; Long, B | 1 |
7 review(s) available for sotalol and procainamide
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[New anti-arrhythmia agents].
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Electrocardiography; Humans; Phenethylamines; Procainamide; Propanolamines; Sotalol; Sulfonamides; Survival Rate; Tachycardia | 1992 |
Effectiveness of sotalol for therapy of complex ventricular arrhythmias and comparisons with placebo and class I antiarrhythmic drugs.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Double-Blind Method; Heart Ventricles; Humans; Multicenter Studies as Topic; Procainamide; Quinidine; Randomized Controlled Trials as Topic; Sotalol | 1990 |
Antiarrhythmic drug therapy of ventricular arrhythmias.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bretylium Tosylate; Disopyramide; Flecainide; Heart Ventricles; Humans; Lidocaine; Mexiletine; Moricizine; Phenothiazines; Phenytoin; Piperidines; Procainamide; Propafenone; Propiophenones; Quinidine; Sotalol; Tocainide; Verapamil | 1986 |
Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amiodarone; Bepridil; Cardiovascular Agents; Disopyramide; Female; Humans; Male; Middle Aged; Prenylamine; Procainamide; Quinidine; Risk Factors; Sex; Sotalol; Syncope; Tachycardia, Ventricular; Torsades de Pointes | 1993 |
Cost-effective management of acute atrial fibrillation: role of rate control, spontaneous conversion, medical and direct current cardioversion, transesophageal echocardiography, and antiembolic therapy.
Topics: Algorithms; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Cost-Benefit Analysis; Echocardiography, Transesophageal; Electric Countershock; Flecainide; Humans; Procainamide; Propafenone; Quinidine; Sotalol; Verapamil | 2000 |
Best Clinical Practice: Emergency Medicine Management of Stable Monomorphic Ventricular Tachycardia.
Topics: Amiodarone; Anti-Arrhythmia Agents; Electric Countershock; Electrocardiography; Emergency Service, Hospital; Evidence-Based Medicine; Humans; Lidocaine; Procainamide; Pyrimidinones; Review Literature as Topic; Sotalol; Tachycardia, Ventricular | 2017 |
14 trial(s) available for sotalol and procainamide
Article | Year |
---|---|
Effectiveness of sotalol for therapy of complex ventricular arrhythmias and comparisons with placebo and class I antiarrhythmic drugs.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Double-Blind Method; Heart Ventricles; Humans; Multicenter Studies as Topic; Procainamide; Quinidine; Randomized Controlled Trials as Topic; Sotalol | 1990 |
Effects of sotalol on ventricular tachycardia and fibrillation produced by programmed electrical stimulation: comparison with other antiarrhythmic agents.
Topics: Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; Electrocardiography, Ambulatory; Electrophysiology; Humans; Multicenter Studies as Topic; Procainamide; Prospective Studies; Sotalol; Tachycardia; Ventricular Fibrillation | 1990 |
Enhanced efficacy of oral sotalol for sustained ventricular tachycardia refractory to type I antiarrhythmic drugs.
Topics: Administration, Oral; Adult; Aged; Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; Clinical Trials as Topic; Drug Evaluation; Electrocardiography; Electrophysiology; Female; Follow-Up Studies; Heart Rate; Heart Ventricles; Humans; Long-Term Care; Male; Middle Aged; Monitoring, Physiologic; Procainamide; Quinidine; Random Allocation; Sotalol; Tachycardia | 1988 |
Comparative efficacy of oral sotalol and procainamide in patients with chronic ventricular arrhythmias: a multicenter study.
Topics: Adult; Aged; Arrhythmias, Cardiac; Chronic Disease; Clinical Trials as Topic; Dose-Response Relationship, Drug; Female; Heart Ventricles; Humans; Male; Middle Aged; Myocardial Contraction; Procainamide; Random Allocation; Sotalol | 1985 |
Effects of amiodarone, sematilide, and sotalol on QT dispersion.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiac Complexes, Premature; Electrocardiography; Follow-Up Studies; Heart Conduction System; Humans; Male; Middle Aged; Procainamide; Retrospective Studies; Sotalol; Tachycardia, Ventricular; Time Factors | 1994 |
Insights into the Electrophysiology Study Versus Electrocardiographic Monitoring Trial: its programmed stimulation protocol may introduce bias when assessing long-term antiarrhythmic drug therapy.
Topics: Anti-Arrhythmia Agents; Bias; Cardiac Pacing, Artificial; Drug Combinations; Electrocardiography, Ambulatory; Electrophysiology; Follow-Up Studies; Humans; Mexiletine; Procainamide; Quinidine; Research Design; Retrospective Studies; Sotalol; Tachycardia, Ventricular | 1995 |
Multicenter trial of sotalol compared with procainamide in the suppression of inducible ventricular tachycardia: a double-blind, randomized parallel evaluation. Sotalol Multicenter Study Group.
Topics: Administration, Oral; Adolescent; Adult; Aged; Cardiac Pacing, Artificial; Double-Blind Method; Electrocardiography; Humans; Infusions, Intravenous; Middle Aged; Procainamide; Sotalol; Tachycardia, Ventricular; Time Factors; Torsades de Pointes; United States | 1995 |
Usefulness of sotalol for life-threatening ventricular arrhythmias.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Female; Humans; Male; Middle Aged; Procainamide; Sotalol | 1993 |
Sotalol and type IA drugs in combination prevent recurrence of sustained ventricular tachycardia.
Topics: Aged; Cardiac Pacing, Artificial; Drug Therapy, Combination; Electrocardiography; Female; Humans; Male; Middle Aged; Procainamide; Prospective Studies; Quinidine; Recurrence; Sotalol; Tachycardia, Ventricular; Treatment Outcome | 1993 |
Effects of antiarrhythmic drugs on variability of ventricular rate and exercise performance in chronic atrial fibrillation complicated with ventricular arrhythmias.
Topics: Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Blood Pressure; Chi-Square Distribution; Chronic Disease; Electrocardiography, Ambulatory; Exercise Tolerance; Female; Heart Rate; Humans; Male; Middle Aged; Procainamide; Propafenone; Sotalol; Tilt-Table Test; Treatment Outcome; Ventricular Dysfunction, Left | 1998 |
Tachycardia-induced change of atrial refractory period in humans: rate dependency and effects of antiarrhythmic drugs.
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Electrocardiography; Electrophysiology; Female; Humans; Male; Middle Aged; Pacemaker, Artificial; Procainamide; Propafenone; Propranolol; Sotalol; Tachycardia, Supraventricular; Verapamil | 1998 |
Rate-control versus conversion strategy in postoperative atrial fibrillation: a prospective, randomized pilot study.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac Surgical Procedures; Digoxin; Drug Administration Routes; Electric Countershock; Electrocardiography; Female; Heart Rate; Humans; Length of Stay; Male; Pilot Projects; Procainamide; Prognosis; Propafenone; Prospective Studies; Recurrence; Sotalol | 2000 |
Comparison of the effects of four antiarrhythmic treatments for familial ventricular arrhythmias in Boxers.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atenolol; Dog Diseases; Dogs; Drug Therapy, Combination; Heart Rate; Mexiletine; Procainamide; Random Allocation; Sotalol; Syncope; Treatment Outcome; Ventricular Premature Complexes | 2002 |
Rate-control versus conversion strategy in postoperative atrial fibrillation: trial design and pilot study results.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmia, Sinus; Atrial Fibrillation; Atrioventricular Node; Calcium Channel Blockers; Cardiac Surgical Procedures; Electric Countershock; Female; Heart Rate; Heart Ventricles; Humans; Length of Stay; London; Male; Middle Aged; Pilot Projects; Postoperative Complications; Procainamide; Propafenone; Prospective Studies; Recurrence; Sotalol; Survival Analysis; Treatment Outcome | 2003 |
36 other study(ies) available for sotalol and procainamide
Article | Year |
---|---|
[3H]Batrachotoxinin A 20 alpha-benzoate binding to voltage-sensitive sodium channels: a rapid and quantitative assay for local anesthetic activity in a variety of drugs.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Anesthetics, Local; Animals; Batrachotoxins; Calcium Channel Blockers; Cyclic AMP; Guinea Pigs; Histamine H1 Antagonists; In Vitro Techniques; Ion Channels; Neurotoxins; Sodium; Tranquilizing Agents; Tritium | 1985 |
ElogD(oct): a tool for lipophilicity determination in drug discovery. 2. Basic and neutral compounds.
Topics: 1-Octanol; Chromatography, High Pressure Liquid; Pharmaceutical Preparations; Solubility; Water | 2001 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
MICE models: superior to the HERG model in predicting Torsade de Pointes.
Topics: ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Humans; Models, Theoretical; Patch-Clamp Techniques; Predictive Value of Tests; Torsades de Pointes | 2013 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Electropharmacology of dofetilide, a new class III agent, in anaesthetised dogs.
Topics: Action Potentials; Anesthesia; Animals; Anti-Arrhythmia Agents; Dogs; Heart; Heart Ventricles; Hemodynamics; Phenethylamines; Potassium Channels; Procainamide; Refractory Period, Electrophysiological; Sotalol; Sulfonamides; Ventricular Fibrillation | 1992 |
Treatment of atrial fibrillation: time for change?
Topics: Anti-Arrhythmia Agents; Anticoagulants; Atrial Fibrillation; Digitalis Glycosides; Digoxin; Humans; Platelet Aggregation Inhibitors; Procainamide; Randomized Controlled Trials as Topic; Sotalol | 1992 |
Cytotoxic interactions of cardioactive cationic amphiphilic compounds in primary rat hepatocytes in culture.
Topics: Amiodarone; Animals; Atenolol; Biomarkers; Cardiotonic Agents; Cell Survival; Cells, Cultured; Dose-Response Relationship, Drug; L-Lactate Dehydrogenase; Liver; Male; Microscopy, Electron; Microscopy, Electron, Scanning; Procainamide; Propranolol; Rats; Rats, Inbred Strains; Sotalol; Verapamil | 1990 |
A comparison of sotalol and procainamide in symptomatic ventricular tachycardia.
Topics: Aged; Electric Stimulation; Electrophysiology; Heart Ventricles; Humans; Middle Aged; Procainamide; Sotalol; Tachycardia | 1989 |
The antiarrhythmic effects of d-sotalol.
Topics: Administration, Oral; Adult; Aged; Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; Electrocardiography; Electrophysiology; Female; Humans; Injections, Intravenous; Male; Middle Aged; Procainamide; Sotalol; Tachycardia; Time Factors | 1987 |
Voltage dependence of cardiac delayed rectifier block by methanesulfonamide class III antiarrhythmic agents.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Dose-Response Relationship, Drug; Electrophysiology; Guinea Pigs; Heart Ventricles; In Vitro Techniques; Phenethylamines; Piperidines; Procainamide; Pyridines; Sotalol; Stereoisomerism; Sulfonamides; Ventricular Function | 1994 |
Effects of sematilide, a novel class III antiarrhythmic agent, on action potential in guinea pig atrium.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Electric Stimulation; Electrophysiology; Guinea Pigs; Heart; Heart Rate; In Vitro Techniques; Male; Myocardium; Procainamide; Refractory Period, Electrophysiological; Sotalol | 1995 |
Comparison of binding to rapidly activating delayed rectifier K+ channel, IKr, and effects on myocardial refractoriness for class III antiarrhythmic agents.
Topics: Animals; Anti-Arrhythmia Agents; Binding, Competitive; Chromans; Electrophysiology; Guinea Pigs; Heart Ventricles; Papillary Muscles; Phenethylamines; Piperidines; Potassium Channel Blockers; Potassium Channels; Procainamide; Pyridines; Sotalol; Structure-Activity Relationship; Sulfonamides; Tritium | 1995 |
Treatment of ventricular tachycardia.
Topics: Humans; Lidocaine; Procainamide; Sotalol; Tachycardia, Ventricular | 1994 |
Undersensing during ventricular tachyarrhythmias in a third-generation implantable cardioverter defibrillator: diagnosis using stored electrograms and correction with programming.
Topics: Aged; Atrial Fibrillation; Defibrillators, Implantable; Electrocardiography; Electrophysiology; Equipment Design; Equipment Failure; Follow-Up Studies; Heart Rate; Humans; Incidence; Information Storage and Retrieval; Male; Middle Aged; Procainamide; Signal Processing, Computer-Assisted; Software; Sotalol; Tachycardia, Ventricular; Ventricular Fibrillation | 1994 |
Comparative mechanisms of antiarrhythmic drug action in experimental atrial fibrillation. Importance of use-dependent effects on refractoriness.
Topics: Animals; Atrial Fibrillation; Atrial Function; Cardiac Pacing, Artificial; Dogs; Electric Stimulation; Female; Heart Conduction System; Male; Procainamide; Propafenone; Sotalol; Vagus Nerve | 1993 |
Membrane activity of class III antiarrhythmic compounds; a comparison between ibutilide, d-sotalol, E-4031, sematilide and dofetilide.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Guinea Pigs; Heart; In Vitro Techniques; Membrane Potentials; Phenethylamines; Piperidines; Potassium Channels; Procainamide; Pyridines; Sotalol; Sulfonamides | 1993 |
Electrophysiologic mechanisms of antiarrhythmic efficacy of a sotalol and class Ia drug combination: elimination of reverse use dependence.
Topics: Action Potentials; Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; Drug Therapy, Combination; Electrocardiography; Female; Humans; Male; Middle Aged; Procainamide; Quinidine; Sotalol; Tachycardia, Ventricular | 1997 |
Characterization of low right atrial isthmus as the slow conduction zone and pharmacological target in typical atrial flutter.
Topics: Adolescent; Adult; Aged; Anti-Arrhythmia Agents; Atrial Flutter; Cardiac Catheterization; Electrophysiology; Female; Heart Atria; Heart Conduction System; Humans; Male; Middle Aged; Procainamide; Sotalol; Tachycardia, Supraventricular | 1997 |
Effects of procainamide and dl-sotalol on the changes of atrial electrophysiology induced by high current stimulation.
Topics: Adult; Aged; Analysis of Variance; Anti-Arrhythmia Agents; Atrial Function; Atrial Premature Complexes; Electric Stimulation; Electrocardiography; Female; Humans; Male; Middle Aged; Neural Conduction; Procainamide; Refractory Period, Electrophysiological; Sotalol; Tachycardia, Atrioventricular Nodal Reentry; Tachycardia, Supraventricular; Wolff-Parkinson-White Syndrome | 1998 |
Proarrhythmia of azimilide and other class III antiarrhythmic agents in the adrenergically stimulated rabbit.
Topics: Adrenergic alpha-Agonists; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Disease Models, Animal; Female; Hemodynamics; Hydantoins; Imidazoles; Imidazolidines; Male; Methoxamine; Phenethylamines; Piperazines; Procainamide; Quaternary Ammonium Compounds; Rabbits; Sotalol; Sulfonamides | 2000 |
Effects of procainamide and sotalol on restitution properties, dispersion of refractoriness, and ventricular fibrillation activation patterns in pigs.
Topics: Animals; Anti-Arrhythmia Agents; Drug Therapy, Combination; Electrocardiography; Heart Conduction System; Heart Rate; Injections, Intramuscular; Procainamide; Refractory Period, Electrophysiological; Sotalol; Swine; Treatment Outcome; Ventricular Fibrillation | 2008 |
Combination antiarrhythmic therapy: 1 + 1 > 2?
Topics: Animals; Anti-Arrhythmia Agents; Drug Therapy, Combination; Electrocardiography; Heart Conduction System; Heart Rate; Injections, Intramuscular; Procainamide; Refractory Period, Electrophysiological; Sotalol; Swine; Treatment Outcome; Ventricular Fibrillation | 2008 |
Intraosseous infusion is unreliable for adenosine delivery in the treatment of supraventricular tachycardia.
Topics: Adenosine; Amiodarone; Catheterization, Central Venous; Combined Modality Therapy; Drug Therapy, Combination; Emergencies; Humans; Infant; Infusions, Intraosseous; Infusions, Intravenous; Male; Procainamide; Propranolol; Recurrence; Sotalol; Tachycardia, Supraventricular; Treatment Failure; Vagus Nerve Stimulation | 2012 |
ECG of the Month. Persistent atrial tachycardia after cardioversion in a horse.
Topics: Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Electric Countershock; Electrocardiography; Horse Diseases; Horses; Male; Procainamide; Sotalol | 2015 |